Growth in the sea comes down to a struggle for iron
Scientists know that injecting iron into some major regions of the oceans can stimulate the growth of diatoms and other phytoplankton, but something odd occurs as these tiny marine plants continue to grow. They begin to starve in the midst of plenty, acting as though iron, an essential nutrient, still is in short supply. Why this happens is unclear, but the answer could be that iron sets off a ki...Improved Outcomes Releases GeneLinker(TM) Gold and Platinum Version 4.6
Improved Outcomes Software (IOS) todayannounced the release of GeneLinker(TM) Gold and Platinum 4.6, newversions of the award-winning Gene Expression and Proteomics AnalysisSoftware products."The new releases are focused primarily on importing and analyzingprotein biomarker data, a high priority for many of our customers. Forexample, we have integrated the Protein Biomarker Package into the...BioMed Central welcomes the new National Institutes of Health public access policy
BioMed Central welcomes the announcement of the US National Institutes of Health (NIH) new public access policy. The NIH calls on all of i...To sea or not to sea: When it comes to salmon sex, size sometimes doesn't matter
The ones that stay and the ones that stray are biological puzzles among Pacific salmon, of whom the vast majority ?but not all ?travel thousands of miles to sea and back to the streams where they hatched. There are chinook salmon populations in Idaho in which an occasional male stays put and matures when only 6 inches long ?that is, he's able to fertilize eggs at even that diminutive size,...When it comes to cell entry, being average has its advantages
When it comes to gaining entry into cells, size matters. A team from Brown University and the Max Planck Institute for Metals Research has created a model that explains how viruses and other bioparticles slip inside cells without a special protein coating called clathrin. The secret, it seems, is to be average. Mid-sized nanomaterials ?about 27 to 30 nanometers in diameter, or about 1,000...A Midwest life-science odyssey comes full circle
D...Daugherty becomes CTO of Great Lakes BioFuels
"We are very pleased to have a partner with Mark's research track record and technology start-up expertise," said H. Tony Hartmann, company CEO. "He is a perfect fit f...Report card praises Wisconsin economy, but comes with warning
Wisconsin made the honor roll of a national economic development assessment group for its high quality of life and quality jobs. The 2006 Development Report Card for the States, released last week by the non-profit Corporation for Enterprise Development, gave the state an A in performance and Bs in business vitality and development capacity, based on 2004 data. But there were a...Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot
Following...Now AIDS treatment comes dirt-cheap
The war of the pharmaceutical giants has just begun. After waging wars over many drug formulations the pharma majors are now locking horns over AIDS treatment. The ball was set in motion by the dramatic announcement of Indian firm Cipla that a three-drug combination for AIDS treatment would cost less than a U.S. dollar a day. Not to be left far behind rival firm Ranbaxy announced...Shorter infants have lower incomes in later life
British researchers have found evidence that male babies who grow slowly in their first year of life have lower incomes in later life. The results hold true regardless of the socioeconomic status of the child's family, suggesting that slow infant growth may be accompanied by hampered brain development. Biological processes linked to poor growth in infancy lead to lifelong impairment of co...Joint replacement surgery outcomes may be affected by obesity and diabetes
Patients who have diabetes or hypertension, or are obese are more likely// to have post surgery complications after having a joint replacement surgery. Joint replacement surgery is done to replace the arthritic or damaged joint with an artificial joint called prosthesis. A joint replacement surgery may be required when moving the muscles of the joint becomes too painful due to injury o...When it comes to health, all chocolates not the same.
European researchers say eating milk chocolate, which is most commonly used in candy bars, does not raise antioxidant levels in the bloodstream. They found the same discouraging result among patients who drank milk while eating dark chocolate.// The results suggest that milk and other dairy products somehow discourage the body's ability to absorb the protective compounds in chocolate. On...Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
Investigators and patients alike look forward to the day when it will be possible to correct the effects of abnormal genes by supplying the body with normal ones. Gene therapy refers to the treatment of a genetic disorder by inserting // normal genes into abnormal cells. The hope is that the transferred genes will cure the basic defect rather than merely alleviating its damage. Getting...Prothrombin Time Comes in Small (CLIA-Waived) Packages
Determining prothombin levels is necessary to plan or evaluate anticoagulant therapy, to diagnose various inherited conditions, such as hyperhomocystinemia, elevated factor VIII levels, dysfibrinogenemia, factor XII deficiency and disorders of plasmin generation, and to assess acquired conditions, such as pregnancy, postoperative state, antiphospholipid syndrome, hyperhomocystinemia, among ot...Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
PHILADELPHIA, July 3, 2007-- – The appearance of arash in cancer patients treated with erlotinib (Tarceva) isstrongly associated with longer survival, according to researchersfrom the drug’s developer, OSI Pharmaceuticals, Inc. This isnot the first time that rash has been associated with a survivaladvantage with EGFR inhibitors – a class of drugs whichincludes erlotinib...Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
RICHMOND, Va.--(BUSINESS WIRE)--Jun 26, 2007 - Insmed Incorporated(Nasdaq:INSM), a biopharmaceutical company focused on thedevelopment and approval of drugs for the treatment of metabolicdiseases with unmet medical needs, today noted the publication ofpromising results of research from three universities regarding thepotential role of insulin-like growth factor binding protein-3(IGFBP-3) in...